(Q28188506)

2

0 references

K Akahori

3

0 references

Y Ishizaki

4

0 references

T Shoji

5

0 references

H Nakagawa

6

0 references

H Hasegawa

7

0 references

S Yoshida

Annals of Allergy, Asthma & Immunology

8

0 references

language of work or name

English

0 references

publication date

August 2001

0 references

published in

0 references

volume

87

0 references

issue

2

0 references

page(s)

146-50

0 references

cites work

Aspirin intolerance in asthma *1, *2Detection by oral challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962210-7

7 January 2021

The diagnosis of aspirin idiosyncrasy by analgesic challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962210-7

7 January 2021

Aspirin and concomitant idiosyncrasies in adult asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962210-7

7 January 2021

Aspirin-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962210-7

7 January 2021

Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962210-7

7 January 2021

Increased urinary excretion of the prostaglandin D2 metabolite 9 alpha, 11 beta-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962210-7

7 January 2021

Bronchial hyperresponsiveness, hypersensitivity to analgesics and urinary leukotriene E4 excretion in patients with aspirin-intolerant asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962210-7

7 January 2021

Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962210-7

7 January 2021

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962210-7

7 January 2021

Serum eosinophil cationic protein as a marker of eosinophilic inflammation in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962210-7

7 January 2021

The evaluation of a cell dispersion method of sputum examination

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962210-7

7 January 2021

Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962210-7

7 January 2021

Therapeutic effect of pranlukast, a selective cysteinyl leukotriene receptor antagonist, on bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962210-7

7 January 2021

Cromolyn sodium prevents bronchoconstriction and urinary LTE4 excretion in aspirin-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962210-7

7 January 2021

Oral and inhaled sodium cromoglycate in challenge test with food allergens or acetylsalicylic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962210-7

7 January 2021

Bronchoalveolar lavage in asthma: the effect of disodium cromoglycate (cromolyn) on leukocyte counts, immunoglobulins, and complement

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962210-7

7 January 2021

Evaluation of serum eosinophilic cationic protein as a marker of disease activity in chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962210-7

7 January 2021

Airway eosinophilic inflammation and bronchial hyperresponsiveness after allergen inhalation challenge in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962210-7

7 January 2021